Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Masamichi Hattori"'
Publikováno v:
IEICE Communications Express.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4afec442d75edfc4f418b9177e883d33
https://doi.org/10.1587/comex.2023xbl0045
https://doi.org/10.1587/comex.2023xbl0045
Publikováno v:
IEICE Communications Express. 10:374-379
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff857245c7ad0dd0211c05db19a85722
https://doi.org/10.1587/comex.2021xbl0088
https://doi.org/10.1587/comex.2021xbl0088
Autor:
Tomomi Takakuwa, Yosuke Otani, Hiroki Okamura, Aji Otake, Sakura Jin, Tomoya Koide, Takashi Hayakawa, Hisashi Kajimura, Yuki Kondo, Hiroki Yamamoto, Izumi Shiroisihi, Masamichi Hattori, Takafumi Nakano, Goro Hanya, Nami Suzuki-Hashido, Takeaki Honda, Yuma Higo, Yosuke Kurihara, Kaori Morishima, Hanami Suzuki, Shun Hongo
Publikováno v:
Ecological Research. 34:842-855
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::573532b0be3ae46cec48c3adcf883dcc
https://doi.org/10.1111/1440-1703.12059
https://doi.org/10.1111/1440-1703.12059
Autor:
Shigeru Tomoyasu, Mayumi Honma, Hidetoshi Nakashima, Bungo Saito, Takako Usui, Daisuke Adachi, Tsuyoshi Nakamaki, Masamichi Hattori
Publikováno v:
Blood. 108:2344-2344
The retinoic acid syndrome (RAS) is a most important complication in all-trans retinoic acid (ATRA)-based remission induction therapy in acute promelocytic leukemia (APL). Predictive factors associated with the development of RAS have not been fully
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7ec5eeb6ea1a95bf78a732ee4f3a560
https://doi.org/10.1182/blood.v108.11.2344.2344
https://doi.org/10.1182/blood.v108.11.2344.2344
Autor:
Takashi Maeda, Hidetoshi Nakashima, Tsuyoshi Nakamaki, Shigeru Tomoyasu, Masamichi Hattori, Takako Usui, Kunihiko Fukuchi
Publikováno v:
Blood. 106:2827-2827
Anaplastic large cell lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (ALCL) is an aggressive T cell lymphoma. CD30 is a characteristic cell surface protein overexpressed in ALCL cells as well as in malignant cells of Hodgkin lymphoma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22a331658b543220775237a05747700e
https://doi.org/10.1182/blood.v106.11.2827.2827
https://doi.org/10.1182/blood.v106.11.2827.2827
Autor:
Shigeru Tomoyasu, Takashi Maeda, Hidetoshi Nakashima, Takako Usui, Masamichi Hattori, Yoshio Honma, Tsuyoshi Nakamaki
Publikováno v:
Blood. 104:3272-3272
Anaplastic large cell lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (ALCL) is a aggressive T cell lymphoma. The 5-year survival rate of ALK-negative ALCL is less than those of ALK-positive ALCL. To address factor(s)involved in maligna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5b83aa54bff9ee9d5e8e99b85a217d1
https://doi.org/10.1182/blood.v104.11.3272.3272
https://doi.org/10.1182/blood.v104.11.3272.3272